Overbought Stocks · Pharmaceutical Preparations
17 stocks match the Overbought Stocks screen. Stocks with an RSI (14) above 70 — technically overbought, most-overbought first. Filtered to Pharmaceutical Preparations. Data as of close · Checked
| PCRX | Pacira Biosciences, Inc. | 0.17 | 0.52 | +1.60% | +23.22% | +45.57% | Golden | 83.00 | 55.1% | Bearish | Bullish | -0.84% | +102.28% | -0.03% | Channel Up | Gravestone Doji | 36.39 | -0.03% |
| REGN | Regeneron Pharmaceuticals | 0.26 | 27.48 | +19.84% | +21.90% | +31.62% | Golden | 82.57 | 99.3% | Bullish | Bullish | -0.14% | +64.59% | -0.34% | Channel Down | — | 973.80 | +1.30% |
| REVB | REVELATION BIOSCIENCES, INC. | 3.48 | 0.33 | +98.33% | +204.03% | +212.85% | Golden | 79.57 | 94.5% | Bullish | Bullish | -21.89% | +914.38% | +10.68% | — | — | 4.51 | +17.58% |
| SLN | Silence Therapeutics Plc | 1.54 | 0.69 | +27.15% | +44.27% | +115.15% | Golden | 78.65 | 98.7% | Bullish | Bullish | -4.72% | +374.58% | +0.10% | — | Spinning Top | 19.79 | +0.13% |
| GMAB | Genmab A/S | 0.74 | 2.38 | +27.93% | +45.97% | +80.58% | Golden | 78.39 | 80.7% | Bullish | Bullish | -7.45% | +134.93% | +1.04% | — | Doji | 55.49 | +1.02% |
| RDY | Dr Reddys Laboratories Ltd | 0.24 | 0.53 | +7.78% | +13.42% | +8.22% | Death | 76.94 | 94.1% | Bullish | Bullish | -10.19% | +30.02% | +0.71% | — | — | 14.31 | +1.31% |
| KRRO | Korro Bio, Inc. | 1.89 | 1.06 | +39.39% | +37.56% | +32.05% | Death | 76.86 | 84.2% | Bullish | Bullish | -61.35% | +204.13% | +2.17% | Channel Down | — | 15.85 | -0.19% |
| INM | InMed Pharmaceuticals Inc. | 0.50 | 0.07 | +18.55% | +20.39% | +36.77% | Golden | 76.39 | 93.7% | Bullish | Bullish | -68.40% | +183.38% | +5.83% | Descending Triangle | — | 1.70 | +4.29% |
| LLY | Lilly (Eli) | 0.30 | 44.73 | +10.69% | +17.02% | +28.67% | Golden | 75.73 | 82.8% | Bullish | Bullish | -2.66% | +65.71% | -0.93% | Head and Shoulders | — | 1409.39 | -0.12% |
| GRFS | Grifols Sa | 1.08 | 0.22 | +10.91% | +12.43% | +6.89% | Death | 75.26 | 88.4% | Bullish | Bullish | -13.59% | +22.83% | +0.29% | Symmetrical Triangle | Doji | 8.55 | +0.59% |
| PHAR | Pharming Group N.V. | 0.80 | 0.39 | +22.85% | +18.16% | -10.07% | Death | 73.37 | 100.0% | Bullish | Bearish | -39.10% | +40.46% | +1.02% | Channel Down | Hanging Man | 12.88 | +1.42% |
| RPRX | Royalty Pharma Plc | 0.13 | 1.60 | +7.28% | +9.70% | +24.04% | Golden | 71.06 | 83.4% | Bullish | Bullish | -2.00% | +84.31% | +0.71% | Descending Triangle | — | 66.35 | -0.26% |
| SNY | Sanofi | 0.22 | 0.89 | +9.27% | +7.45% | +2.30% | Death | 70.82 | 94.0% | Bullish | Bullish | -13.94% | +16.02% | +0.19% | Channel Down | — | 45.33 | -0.46% |
| CMND | Clearmind Medicine Inc. | -1.46 | 0.31 | +11.55% | +102.62% | -21.87% | Death | 70.76 | 19.0% | Bearish | Bearish | -84.04% | +751.54% | +0.50% | — | — | 6.04 | +0.50% |
| VRDN | Viridian Therapeutics, Inc.De | 0.94 | 1.59 | +16.39% | +15.75% | +15.89% | Golden | 70.73 | 86.3% | Bullish | Bullish | -28.20% | +109.42% | +3.01% | — | — | 25.13 | -0.59% |
| UTHR | United Therapeutics Corp | 0.20 | 15.56 | +6.23% | +13.43% | +12.93% | Death | 70.27 | 91.2% | Bullish | Bullish | -1.21% | +39.90% | +0.40% | Channel Up | — | 601.74 | +0.95% |
| DMAC | DiaMedica Therapeutics Inc. | 1.55 | 0.51 | +16.72% | +29.44% | +40.61% | Golden | 70.09 | 98.8% | Bullish | Bullish | -8.91% | +104.07% | +0.91% | Channel Up | Bullish Marubozu | 10.02 | +7.63% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.